These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 126971)

  • 1. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW; James TA
    Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation between GABAergic and dopaminergic neurons in the basal ganglia].
    Kemel ML; Gauchy C; Girault JA; Besson JM; Glowinski J
    Encephale; 1987 Jul; 13 Spec No():169-71. PubMed ID: 3319524
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of catecholamines in regulating motor functions (review)].
    Barkhatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):1068-74. PubMed ID: 2863909
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of ethanol on the motor activity of rats and on the content of GABA and dopamine and its metabolites in the nigrostriatal system].
    Karpova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(5):1027-30. PubMed ID: 1336265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Morphofunctional features of the substantia nigra, its role in brain pathology and the action of pharmacologic substances].
    Arushanian EB
    Usp Fiziol Nauk; 1979; 10(2):45-72. PubMed ID: 38580
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropeptides in the basal ganglia.
    Graybiel AM
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 10. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 11. GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions.
    Scheel-Krüger J
    Adv Neurol; 1984; 40():85-90. PubMed ID: 6141713
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of GABA neurons in the expression of striatal motor functions.
    Di Chiara G; Porceddu ML; Imperato A; Morelli M
    Adv Biochem Psychopharmacol; 1981; 30():129-63. PubMed ID: 7036674
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The striopallidal system: Its implication in motor disorders.
    Poirier LJ; Parent A; Roberge AG
    Pathobiol Annu; 1975; 5():339-67. PubMed ID: 812038
    [No Abstract]   [Full Text] [Related]  

  • 15. Complex functions of basal ganglia.
    Teuber HL
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():151-68. PubMed ID: 826995
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo release of newly synthesized GABA in the basal ganglia of the cat.
    Gauchy C; Kemel ML; Glowinski J; Besson MJ
    Adv Biochem Psychopharmacol; 1981; 29():183-91. PubMed ID: 7257927
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution and release of GABA in the basal ganglia.
    Korf J; van der Heyden JA; Venema K; Postema F
    Adv Biochem Psychopharmacol; 1981; 30():105-17. PubMed ID: 7331934
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.